Breast implant maker Sientra Inc said it will resume
promoting all of its scientific devices within the U.S.
marketplace from March 1, four months after it suspended income of its breast
implant gadgets to ensure technical compliance.
The company had positioned a maintain on income of its
implants in October, mentioning some technical compliance troubles at Brazilian
contract producer Silimed's plant.
Sientra said on Monday it has additionally despatched a
letter to its surgeons informing them of the company's market re-entry plans.
No comments:
Post a Comment